|Year : 2019 | Volume
| Issue : 3 | Page : 235-236
131I uptake in bronchiectasis detected by single photon emission computed tomography/computed tomography during follow-up of thyroid cancer
Ferdinando Calabria1, Antonio Lanzillotta1, Mario Leporace1, Giuliana Guadagnino2, Orazio Schillaci3, Antonio Bagnato1
1 Department of Nuclear Medicine and Theranostics, “Mariano Santo” Hospital, 87100, Cosenza, Italy
2 Department of Infectious and Tropical Diseases, “St. Annunziata” Hospital, 87100, Cosenza, Italy
3 Department of Biomedicine and Prevention, University “Tor Vergata”, Rome; Department of Nuclear Medicine and Molecular Imaging, IRCCS INM Neuromed, Pozzilli (IS), Italy
|Date of Web Publication||20-Jun-2019|
Dr. Ferdinando Calabria
Department of Nuclear Medicine and Theranostics, “Mariano Santo” Hospital, 87100, Cosenza
Source of Support: None, Conflict of Interest: None
| Abstract|| |
During follow-up of thyroid cancer, 131I whole-body scan showed intense tracer uptake in the right hemithorax of a patient previously submitted to thyroidectomy and radioiodine therapy for differentiated thyroid cancer. Thyroglobulin was undetectable at the time of the scan. Single-photon emission computed tomography/computed tomography (SPECT/CT) of the thorax correctly identified widespread bronchiectasis 131I-avid in the middle lobe of the right lung. After bronchoalveolar lavage, a bronchial specimen was positive for Mycobacterium avium infection. Hybrid imaging with SPECT/CT allowed to correctly identify a false-positive case of 131I uptake due to inflammation in a single diagnostic session, minimizing patient discomfort or misdiagnoses.
Keywords: 131I, bronchiectasis, pitfalls, single-photon emission computed tomography/computed tomography, uptake
|How to cite this article:|
Calabria F, Lanzillotta A, Leporace M, Guadagnino G, Schillaci O, Bagnato A. 131I uptake in bronchiectasis detected by single photon emission computed tomography/computed tomography during follow-up of thyroid cancer. Indian J Nucl Med 2019;34:235-6
|How to cite this URL:|
Calabria F, Lanzillotta A, Leporace M, Guadagnino G, Schillaci O, Bagnato A. 131I uptake in bronchiectasis detected by single photon emission computed tomography/computed tomography during follow-up of thyroid cancer. Indian J Nucl Med [serial online] 2019 [cited 2019 Jul 16];34:235-6. Available from: http://www.ijnm.in/text.asp?2019/34/3/235/260745
A 46-year-old female underwent thyroidectomy for differentiated thyroid cancer [Figure 1]. Postoperative 131I whole-body scan showed tracer uptake, higher than surrounding background, in the neck (a) and in the right hemithorax (a, arrow). The patient underwent radioiodine therapy (1850 MBq). Nine months after, the patient underwent 131I whole-body scan (b): diffuse 131I uptake was observed in the right hemithorax; thyroglobulin serum level was 0.1 ng/ml at the time of the second 131I scan, but the patient's anamnesis was positive for chronic dyspnea and cough. Single-photon emission computed tomography/computed tomography (SPECT/CT) was performed. CT (c) and SPECT/CT (d) showed 131I uptake in widespread bronchiectasis in the middle lobe of the right lung.
|Figure 1: Postoperative 131I whole-body scan shows tracer uptake in the neck (a) and in the right hemithorax (a, arrow). A following further 131I whole-body scan confirms diffuse 131I uptake in the right hemithorax (b); CT (c) and SPECT/CT (d) showed 131I uptake in association with bronchiectasis in the middle lobe of the right lung. A CT of the thorax (e) performed at follow-up, showed partial resolution of bronchiectasis|
Click here to view
A bronchial specimen was positive for Mycobacterium avium infection. CT of the thorax (e), performed at 3-month follow-up, showed partial resolution of bronchiectasis.
131I is a useful radiopharmaceutical in imaging thyroid cancer; it is well known the possibility to detect 131I uptake in inflammatory lesions. Moreover, other malignant tumors show 131I-avid uptake that can be managed by SPECT/CT.
Hybrid scanners allowed nuclear medicine physicians to identify diagnostic pitfalls occurring in clinical practice. Similarly, to other reports on this topic,, the use of CT with “lung window” allowed to identify diffuse 131I-avid bronchiectasis in a single diagnostic session, minimizing patient discomfort. The 131I uptake in bronchiectasis is due to expression of sodium-iodide symporter in secretions. Nuclear medicine physicians should be aware of tracer physiological distribution and pitfalls, to avoid misdiagnosis. Laboratory data, expertise on CT, and hybrid imaging are of the utmost importance.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Pitoia F, Bueno F, Cross G. Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131
Iodine-avid lung metastasis from differentiated thyroid cancer. Clin Nucl Med 2014;39:784-90.
Jia C, Moadel R, Freeman LM. Focal thoracic uptake mimicking lung metastasis on 131
I post-therapy whole-body scan in patients with thyroid carcinoma. Clin Nucl Med 2014;39:360-2.
Sainz-Esteban A, de Luis Román D, García-Talavera San Miguel P, Pacheco Sánchez D, González Selma ML, Ruiz Gómez MÁ, et al.
Incidental finding on a SPECT/CT of a retroperitoneal leiomyosarcoma imitating a hiatal hernia in 131
I whole-body scan in thyroid cancer evaluation. Rev Esp Med Nucl Imagen Mol 2013;32:406-7.
Calabria F. Fifty shades of meningioma: Challenges and perspectives of different PET molecular probes. Clin Transl Imaging 2017;5:403-5.
Padma S, Sundaram PS, Firuz MD. Bronchiectasis masquerading as lung metastasis in a patient with papillary carcinoma thyroid identified by 131
I whole body scintigraphy. J Nucl Med Radiat Ther 2015;6:252.
Espírito Santo R, Marques P, João Bugalho M. False-positive uptake on radioiodine whole-body scan due to bronchiectasis. BMJ Case Rep 2015;2015. pii: bcr2015213169.
Glazer DI, Brown RK, Wong KK, Savas H, Gross MD, Avram AM. SPECT/CT evaluation of unusual physiologic radioiodine biodistributions: Pearls and pitfalls in image interpretation. Radiographics 2013;33:397-418.
Tagliabue L, Schillaci O. SPECT/CT in oncology: The fusion of two imaging modalities is a new standard of care. Q J Nucl Med Mol Imaging 2007;51:285-9.